# Development and Validation of a Machine Learning-Based Dementia Screening Tool: The Six-Question Dementia Screening Test

**Authors:** Meng-Tien Wu, Kuan-Ying Li, Ching-Fang Chien, Ling-Chun Huang, Chen-Wen Yen, Yuan-Han Yang

PMC · DOI: 10.1177/15333175261424333 · American Journal of Alzheimer's Disease and Other Dementias · 2026-02-17

## TL;DR

A new six-question machine learning tool for dementia screening is developed and validated, offering high accuracy and ease of use.

## Contribution

A novel dementia screening tool using machine learning that is brief and highly accurate compared to existing methods.

## Key findings

- The 6Q-DS achieved an AUC of 0.936, sensitivity 0.879, specificity 0.951, and accuracy 0.907 for dementia detection.
- It performed comparably to MMSE and CASI while being more practical and user-friendly.
- For very mild dementia detection, the 6Q-DS had an AUC of 0.874, sensitivity 0.818, and accuracy 0.810.

## Abstract

Timely detection of dementia is crucial for reducing its health and societal burden. Standard tools such as the Mini-Mental State Examination (MMSE) and Cognitive Abilities Screening Instrument (CASI), although widely used, are limited by time and resource demands. This study developed and validated a machine learning–based screening tool using the Six-Question Dementia Screening Test (6Q-DS), a brief interview of six items. Data from 533 older adults at a neurology clinic in Taiwan (331 with dementia, 202 without) were analyzed with eXtreme Gradient Boosting. The 6Q-DS achieved an AUC of 0.936, sensitivity 0.879, specificity 0.951, and accuracy 0.907 for dementia vs non-dementia. For identifying very mild dementia vs non-dementia, the AUC was 0.874, with a sensitivity of 0.818, specificity of 0.805, and accuracy of 0.810. Comparable to MMSE and CASI, the 6Q-DS provides a practical, rapid, and user-friendly tool for dementia screening.

## Linked entities

- **Diseases:** dementia (MONDO:0001627)

## Full-text entities

- **Genes:** AD8 (Alzheimer disease 8) [NCBI Gene 353128]
- **Diseases:** Cognitive Impairment (MESH:D003072), Movement Disorder (MESH:D009069), rapid eye movement sleep behavior disorder (MESH:D020187), memory impairment (MESH:D008569), Dementia (MESH:D003704), parkinsonism (MESH:D010302), facial asymmetry (MESH:D005146), depressed (MESH:D003866), cerebrovascular disease (MESH:D002561), neurocognitive disorders (MESH:D019965), vascular dementia (MESH:D015140), hallucinations (MESH:D006212), pseudodementia (MESH:D005162), Neurological Disorders and Stroke (MESH:D009461), DLB (MESH:D020961), ORCID iDs (MESH:C535742), psychiatric illness (MESH:D001523), ND (MESH:C537849), impairs (MESH:D060825), AD (MESH:D000544), PD (MESH:D010300)
- **Chemicals:** 6Q-DS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921207/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921207/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921207/full.md

---
Source: https://tomesphere.com/paper/PMC12921207